EcoNugenics, Inc. is a pioneering supplement company established in 1995 with a commitment to delivering exceptional, natural solutions for health. Formulated by renowned physician Isaac Eliaz, MD, MS, LAc, their products are backed by extensive research and are highly recommended by health practitioners globally. The flagship offering, PectaSol-C®, is the sole clinically substantiated modified citrus pectin in the market, supported by over 25 years of research and 65 peer-reviewed studies.
Specializing in Health Care, ecoNugenics® has built a reputation for providing targeted, high-value nutraceutical supplements derived from nature, science, and peer-reviewed research. Their innovative approach has positioned them as a recognized leader in the industry, with a strong focus on product efficacy and natural solutions.
While specific information about their headquarter and past investment details is not provided, their consistent focus on research-backed, natural formulations and their continuous impact on health care solutions make them a compelling prospect for potential investors seeking opportunities in the health and wellness sector.
There is no investment information
No recent news or press coverage available for EcoNugenics, Inc..